EUVIMEDEUVIMED entdecken
Crossref

Plasma Epstein–Barr Virus DNA and Risk of Future Nasopharyngeal Cancer

K C Allen Chan, W K Jacky Lam, Ann King, Vivien S Lin, Patrick P H Lee, Benny C Y Zee, Stephen L Chan, Irene O L Tse, Amy F C Tsang, Maggie Z J Li, Peiyong Jiang, Qi Yong H Ai und 8 weitere

NEJM Evidence · 27.06.2023 · 2 (7)

DOI: 10.1056/evidoa2200309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NEJM Evidence, erschienen am 27.06.2023. Verfasst von K C Allen Chan und 19 weiteren Autor:innen. Beteiligte Einrichtung: Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasopharyngeal NeoplasmsEpstein-Barr Virus InfectionsHumansNasopharyngeal CarcinomaHerpesvirus 4, HumanPrognosisDNA, Viral

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
  • Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
  • State Key Laboratory of Translational Oncology, Sir Y.K. Pao Centre for Cancer, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
  • Centre for Novostics, The Chinese University of Hong Kong, Hong Kong Science and Technology Park, Pak Shek Kok, New Territories, Hong Kong SAR, China.
  • Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
  • Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.

Zitieren

APA

Chan, K. C. A., Lam, W. K. J., King, A., Lin, V. S., Lee, P. P. H., Zee, B. C. Y., Chan, S. L., Tse, I. O. L., Tsang, A. F. C., Li, M. Z. J., Jiang, P., Ai, Q. Y. H., Poon, D. M. C., Au, K. H., Hui, E. P., Ma, B. B. Y., Van Hasselt, A. C., Chan, A. T. C., Woo, J. K. S., & Lo, Y. M. D. (2023). Plasma Epstein–Barr Virus DNA and Risk of Future Nasopharyngeal Cancer. NEJM Evidence, 2(7). https://doi.org/10.1056/evidoa2200309

Vancouver

Chan KCA, Lam WKJ, King A, Lin VS, Lee PPH, Zee BCY, et al. Plasma Epstein–Barr Virus DNA and Risk of Future Nasopharyngeal Cancer. NEJM Evidence. 2023;2(7). doi:10.1056/evidoa2200309

BibTeX
@article{Chan2023,
  author = {Chan, K C Allen and Lam, W K Jacky and King, Ann and Lin, Vivien S and Lee, Patrick P H and Zee, Benny C Y and Chan, Stephen L and Tse, Irene O L and Tsang, Amy F C and Li, Maggie Z J and Jiang, Peiyong and Ai, Qi Yong H and Poon, Darren M C and Au, K H and Hui, Edwin P and Ma, Brigette B Y and Van Hasselt, Andrew C and Chan, Anthony T C and Woo, John K S and Lo, Y M Dennis},
  title = {Plasma Epstein–Barr Virus DNA and Risk of Future Nasopharyngeal Cancer},
  journal = {NEJM Evidence},
  year = {2023},
  volume = {2},
  number = {7},
  doi = {10.1056/evidoa2200309}
}
Kostenlos starten →